A detailed history of Empire Life Investments Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Empire Life Investments Inc. holds 98,688 shares of LEGN stock, worth $3.97 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
98,688
Previous 56,320 75.23%
Holding current value
$3.97 Million
Previous $2.49 Million 92.82%
% of portfolio
0.3%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$43.55 - $59.88 $1.85 Million - $2.54 Million
42,368 Added 75.23%
98,688 $4.81 Million
Q2 2024

Jul 31, 2024

BUY
$39.5 - $57.22 $2.22 Million - $3.22 Million
56,320 New
56,320 $2.49 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Empire Life Investments Inc. Portfolio

Follow Empire Life Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empire Life Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Empire Life Investments Inc. with notifications on news.